Lexicon Pharmaceuticals
LXRX
#7493
Rank
S$0.53 B
Marketcap
S$1.48
Share price
-19.44%
Change (1 day)
41.91%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): S-$0.26

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.24. In 2024 the company made an earnings per share (EPS) of S-$0.81 an increase over its 2023 EPS that were of S-$1.02.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.26-68.65%
2024S-$0.81-20%
2023S-$1.0231.15%
2022S-$0.78-0%
2021S-$0.7810.91%
2020S-$0.70-145.08%
2019S$1.55-206.09%
2018S-$1.46-5.74%
2017S-$1.55-10.95%
2016S-$1.742640%
2015S-$0.06360-96.34%
2014S-$1.74-2.53%
2013S-$1.78-9.09%
2012S-$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$22.06-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$5.69-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$55.26-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.56 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.04-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.64 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.95 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$3.46-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$97.58 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA